Tempest Therapeutics Inc.(TPST),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

TPST Tempest Therapeutics Inc.

Post-Mkt 02-05 16:40:16 EST

2.23

-0.15

-6.30%

盘后2.29

+0.06+2.69%

16:29 EST

High2.40	Low2.17	Vol151.07K
Open2.19	D1 Closing2.38	Amplitude9.66%
Mkt Cap10.99M	Tradable Cap10.37M	Total Shares4.93M
T/O339.85K	T/O Rate3.25%	Tradable Shares4.65M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"TPST","market":"US","secType":"STK","nameCN":"Tempest Therapeutics Inc.","latestPrice":2.23,"timestamp":1770325200000,"preClose":2.38,"halted":0,"volume":151067,"hourTrading":{"tag":"盘后","latestPrice":2.29,"preClose":2.23,"latestTime":"16:29 EST","volume":401,"amount":874.4149459,"timestamp":1770326947145,"change":0.06,"changeRate":0.026906,"amplitude":0.053812},"delay":0,"changeRate":-0.06302521008403358,"floatShares":4650800,"shares":4927161,"eps":-10.103,"marketStatus":"Post-Mkt","change":-0.15,"latestTime":"02-05 16:40:16 EST","open":2.19,"high":2.4,"low":2.17,"amount":339849.7941,"amplitude":0.096639,"askPrice":2.33,"askSize":7,"bidPrice":2.17,"bidSize":204,"shortable":3,"etf":0,"ttmEps":-10.103,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1770339600000},"marketStatusCode":4,"adr":0,"exchange":"NASDAQ","adjPreClose":2.38,"preHourTrading":{"tag":"盘前","latestPrice":2.1923,"preClose":2.38,"latestTime":"09:27 EST","volume":20973,"amount":46300.7162712,"timestamp":1770301676652,"change":-0.1877,"changeRate":-0.078866,"amplitude":0.052269},"postHourTrading":{"tag":"盘后","latestPrice":2.29,"preClose":2.23,"latestTime":"16:29 EST","volume":401,"amount":874.4149459,"timestamp":1770326947145,"change":0.06,"changeRate":0.026906,"amplitude":0.053812},"volumeRatio":0.475218,"impliedVol":1.4125,"impliedVolPercentile":0.2727},"requestUrl":"/m/hq/s/TPST/tweets","defaultTab":"tweets","newsList":[{"id":"2609166143","title":"BRIEF-Tempest Announces Closing Of Strategic Acquisition Of Dual-Targeting Car-T Assets","url":"https://stock-news.laohu8.com/highlight/detail?id=2609166143","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609166143?lang=en_us&edition=fundamental","pubTime":"2026-02-05 05:47","pubTimestamp":1770241655,"startTime":"0","endTime":"0","summary":"BRIEF-Tempest Announces Closing Of Strategic Acquisition Of Dual-Targeting Car-T AssetsFeb 4 (Reuters) - Tempest Therapeutics Inc TPST.O:TEMPEST ANNOUNCES CLOSING OF STRATEGIC ACQUISITION OF DUAL-TARG","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260204:nTUA3FFHTY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TPST","BK4139"],"gpt_icon":0},{"id":"2609831665","title":"Tempest Announces Closing of Strategic Acquisition of Dual-Targeting CAR-T Assets","url":"https://stock-news.laohu8.com/highlight/detail?id=2609831665","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609831665?lang=en_us&edition=fundamental","pubTime":"2026-02-05 05:47","pubTimestamp":1770241633,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260204:nTUA3FFHTY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TPST","BK4139"],"gpt_icon":0},{"id":"2602930138","title":"Tempest Therapeutics Faces Nasdaq Delisting Notice Over Missed Annual Meeting Deadline","url":"https://stock-news.laohu8.com/highlight/detail?id=2602930138","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602930138?lang=en_us&edition=fundamental","pubTime":"2026-01-10 05:16","pubTimestamp":1767993373,"startTime":"0","endTime":"0","summary":"Tempest Therapeutics Inc. is facing a regulatory issue related to its continued listing on the Nasdaq Stock Market. The company failed to hold its annual meeting of stockholders within twelve months of the end of its fiscal year on December 31, 2024, which is a requirement under Nasdaq Listing Rules 5620 and 5810. As a result, Nasdaq has notified Tempest Therapeutics of its non-compliance. The company has 45 days from January 8, 2026, to regain compliance or submit a plan to do so, and could be granted up to 180 days from the fiscal year end to resolve the issue. Holding the scheduled 2025 Annual Meeting would bring the company back into compliance with Nasdaq requirements.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260109:nNDL1fHbHZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TPST","BK4139"],"gpt_icon":0},{"id":"2588828068","title":"Tempest Therapeutics Inc. Announces Date for Upcoming Annual Stockholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2588828068","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588828068?lang=en_us&edition=fundamental","pubTime":"2025-12-03 01:59","pubTimestamp":1764698385,"startTime":"0","endTime":"0","summary":"Tempest Therapeutics Inc. will hold its Annual Meeting of Stockholders on December 31, 2025. During the meeting, shareholders will vote on the election of the Board's Class I nominee, Geoff Nichol, to the Board of Directors.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tempest Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 02, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251202:nNDL61gJGs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TPST"],"gpt_icon":0},{"id":"2586604302","title":"BRIEF-Tempest Announces Closing Of Up To $8.35 Million Registered Direct Offering Of Common Stock And Concurrent Private Placement Of Warrants Priced At-The-Market Under Nasdaq Rules","url":"https://stock-news.laohu8.com/highlight/detail?id=2586604302","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586604302?lang=en_us&edition=fundamental","pubTime":"2025-11-27 05:12","pubTimestamp":1764191561,"startTime":"0","endTime":"0","summary":"BRIEF-Tempest Announces Closing Of Up To $8.35 Million Registered Direct Offering Of Common Stock And Concurrent Private Placement Of Warrants Priced At-The-Market Under Nasdaq RulesNov 26 (Reuters) -","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251126:nTUA21MRVL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TPST"],"gpt_icon":0},{"id":"2586609792","title":"Tempest Therapeutics Raises $8.35 Million Through Registered Direct Offering and Private Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2586609792","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586609792?lang=en_us&edition=fundamental","pubTime":"2025-11-27 05:05","pubTimestamp":1764191114,"startTime":"0","endTime":"0","summary":"Tempest Therapeutics Inc. announced the closing of a registered direct offering and a concurrent private placement, raising $4.25 million upfront. The company sold 1,172,414 shares of common stock at $3.625 per share in the registered direct offering. In the concurrent private placement, Tempest issued short-term unregistered warrants to purchase up to 1,172,414 shares of common stock at an exercise price of $3.50 per share. The warrants are immediately exercisable and will expire eighteen months after the effective date of the registration statement for the underlying shares. The private placement and the shares issuable upon exercise of the warrants were offered under Section 4 of the Securities Act of 1933 and/or Regulation D, and are not registered under the Act or applicable state securities laws. Up to an additional $4.1 million in gross proceeds may be raised if the warrants are fully exercised.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251126:nNDL3qYPxF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TPST","BK4588","BK4139","LU2095319765.USD","IE00BKPKM429.USD","IE00B3QW5Z07.USD","LU2210150020.SGD","NDAQ","IE00B64PRP62.GBP","BK4112","IE00BGHQF748.EUR","LU2210149790.SGD","LU0314104364.USD","BK4585"],"gpt_icon":0},{"id":"2586053934","title":"Top Midday Decliners","url":"https://stock-news.laohu8.com/highlight/detail?id=2586053934","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586053934?lang=en_us&edition=fundamental","pubTime":"2025-11-26 03:28","pubTimestamp":1764098900,"startTime":"0","endTime":"0","summary":"Tempest Therapeutics (TPST) reported Tuesday a registered direct offering of common stock expected to raise $4.25 million from a single healthcare-focused institutional investor, with potential additi","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NVDU","NVD","NVDD","GFS","LU1839511570.USD","BK4579","NVIW.SI","LU2931357623.SGD","3NVD.UK","LU0477156953.USD","LU2098885051.SGD","LU2463028550.USD","NVD2.UK","AMD.AU","LU2092937148.SGD","LU2125909759.SGD","BK4561","GB00B4QBRK32.GBP","LU0347712357.USD","LU1951198990.SGD","BK4548","LU1564329115.USD","LU0109392836.USD","LU2756315318.SGD","NVDY","NVD3.UK","2NVD.UK","TPST","LU0957808578.USD","LU1059921491.USD","NVDS.UK","LU1366333091.USD","BK4549","LU0889566641.SGD","SNVD.UK","USJW.SI","NVDS","SG9999015986.USD","LU2133065610.SGD","LU1429558221.USD","LU0128525689.USD","LU2322448957.HKD","LU0823414551.USD"],"gpt_icon":1},{"id":"2586473199","title":"Tempest Therapeutics Announces Private Placement of Unregistered Warrants for Up to $4.1 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2586473199","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586473199?lang=en_us&edition=fundamental","pubTime":"2025-11-25 21:00","pubTimestamp":1764075632,"startTime":"0","endTime":"0","summary":"Tempest Therapeutics Inc. has announced a private placement involving the sale of short-term unregistered warrants to purchase up to 1,172,414 shares of common stock at an exercise price of $3.50 per share. The warrants, issued in a concurrent private placement alongside a registered direct offering of common stock, are immediately exercisable and will expire eighteen months after the effective date of the registration statement covering the underlying shares. The private placement was conducted under Section 4 of the Securities Act and Regulation D, meaning the warrants and shares issuable upon exercise have not been registered and may not be sold in the United States without proper registration or exemption. Tempest expects to receive up to $4.1 million in additional gross proceeds if all warrants are exercised.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this A","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251125:nNDL4Fsk7N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LU2095319765.USD","LU2210149790.SGD","IE00BKPKM429.USD","LU0314104364.USD","IE00B3QW5Z07.USD","BK4112","TPST","LU2210150020.SGD","BK4585","IE00BGHQF748.EUR","NDAQ","IE00B64PRP62.GBP","BK4588"],"gpt_icon":0},{"id":"2586473668","title":"Tempest Announces up to $8.35 Million Registered Direct Offering of Common Stock and Concurrent Private Placement of Warrants Priced at-the-Market Under Nasdaq Rules","url":"https://stock-news.laohu8.com/highlight/detail?id=2586473668","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586473668?lang=en_us&edition=fundamental","pubTime":"2025-11-25 21:00","pubTimestamp":1764075602,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251125:nTUA4FZG8H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TPST","BK4139"],"gpt_icon":0},{"id":"2586473427","title":"Tempest Therapeutics Inc - Entered Definitive Agreement for Purchase & Sale of 1.2 Mln Common Shares at $3.625 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2586473427","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586473427?lang=en_us&edition=fundamental","pubTime":"2025-11-25 21:00","pubTimestamp":1764075602,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251125:nTUA4FZG8H:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","TPST"],"gpt_icon":0},{"id":"2584927918","title":"Crude Oil Falls Over 2%; Lowe's Shares Gain After Q3 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2584927918","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584927918?lang=en_us&edition=fundamental","pubTime":"2025-11-20 01:58","pubTimestamp":1763575133,"startTime":"0","endTime":"0","summary":" ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"90b832db26fd011e7a440a8a42528042","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/market-summary/25/11/48957034/crude-oil-falls-over-2-lowes-shares-gain-after-q3-results","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SEMR","BK4023","LU1074936037.SGD","TSYW.SI","LU2237443622.USD","LU1674673691.USD","NVIW.SI","BK4539","BK4581","LU0868494617.USD","LU2237443382.USD","BK4083","IE0034235188.USD","LU0312595415.SGD","LU1778281490.HKD","TPST","BK4588","LU0302445910.USD","LU1506573853.SGD",".IXIC","LU2237443465.HKD","BK4534","WSHP","LU0314106906.USD","LU2237443895.HKD","BK4131","BK4585","BK4211","SQQQ","USJW.SI","CARV","AGIO","MNQmain","QID","USAW.SI","PSQ","QLD","BK4164","LU0198837287.USD","LU1674673428.USD","LU0942090050.USD","LOW","LU2275660780.HKD","FRGT","BK4195","BK4532","BK4139","TQQQ","NQmain"],"gpt_icon":1},{"id":"2584092686","title":"Tempest Therapeutics Q3 EPS USD -0.79","url":"https://stock-news.laohu8.com/highlight/detail?id=2584092686","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584092686?lang=en_us&edition=fundamental","pubTime":"2025-11-20 00:39","pubTimestamp":1763570375,"startTime":"0","endTime":"0","summary":"Nov 5 (Reuters) - Tempest Therapeutics Inc ::*TEMPEST THERAPEUTICS Q3 EPS USD -0.79*TEMPEST THERAPEUTICS Q3 NET INCOME USD -3.511 MILLION*TEMPEST THERAPEUTICS Q3 OPERATING INCOME USD -3.597 MILLION*Fu","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251119:nRSD8v3N5w:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TPST","BK4139"],"gpt_icon":0},{"id":"2584925771","title":"Why Tempest Therapeutics (TPST) Stock Is Down 45% Today","url":"https://stock-news.laohu8.com/highlight/detail?id=2584925771","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584925771?lang=en_us&edition=fundamental","pubTime":"2025-11-20 00:33","pubTimestamp":1763569980,"startTime":"0","endTime":"0","summary":"Tempest Therapeutics shares fell Wednesday after the announcement of an all-stock acquisition of dual-CAR T programs from Factor Bioscience.","market":"nz","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/11/19/Stock-Market-Trading-Graph-And-Financial.jpeg?optimize=medium&dpr=2&auto=webp&width=260","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/11/19/Stock-Market-Trading-Graph-And-Financial.jpeg?optimize=medium&dpr=2&auto=webp&width=260"],"rights":{"source":"benzinga_hot_news","url":"https://www.benzinga.com/trading-ideas/movers/25/11/48954607/why-tempest-therapeutics-tpst-stock-is-down-45-today","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/trading-ideas/movers/25/11/48954607/why-tempest-therapeutics-tpst-stock-is-down-45-today","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_hot_news","symbols":["TPST","BK4139"],"gpt_icon":0},{"id":"2584942745","title":"Tempest Therapeutics Announces Private Placement of Unregistered Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2584942745","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584942745?lang=en_us&edition=fundamental","pubTime":"2025-11-19 22:17","pubTimestamp":1763561851,"startTime":"0","endTime":"0","summary":"Tempest Therapeutics Inc. has announced the sale and issuance of shares of its common stock in a private placement in connection with its asset purchase agreement with Erigen LLC and Factor Bioscience Inc. The shares are being offered in a private placement under Section 4 of the Securities Act of 1933 and have not been registered under the Securities Act. As a result, these securities may not be offered or sold in the United States without an effective registration statement or a valid exemption from registration requirements.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tempest Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system o","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251119:nNDL3jNh9S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TPST","BK4139"],"gpt_icon":0},{"id":"2584944706","title":"Tempest Therapeutics Inc - Matt Angel to Become President and CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=2584944706","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584944706?lang=en_us&edition=fundamental","pubTime":"2025-11-19 22:00","pubTimestamp":1763560815,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251119:nTUA20FZ9C:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TPST","BK4139"],"gpt_icon":0},{"id":"2584944085","title":"Tempest Announces Strategic Acquisition of New Dual-Car T Programs From Factor With Simultaneous Runway Extension Projected to Mid 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2584944085","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584944085?lang=en_us&edition=fundamental","pubTime":"2025-11-19 22:00","pubTimestamp":1763560815,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251119:nTUA20FZ9C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TPST","BK4139"],"gpt_icon":0},{"id":"2584794401","title":"Tempest Therapeutics Inc - Investment Commitment to Support Operations to Mid 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2584794401","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584794401?lang=en_us&edition=fundamental","pubTime":"2025-11-19 22:00","pubTimestamp":1763560815,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251119:nTUA20FZ9C:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","TPST"],"gpt_icon":0},{"id":"2584447709","title":"Tempest Therapeutics Inc:  Stephen Brady to Assume Role of Chairman of Board Upon Closing of Acquisition","url":"https://stock-news.laohu8.com/highlight/detail?id=2584447709","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584447709?lang=en_us&edition=fundamental","pubTime":"2025-11-19 22:00","pubTimestamp":1763560815,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251119:nTUA20FZ9C:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","TPST"],"gpt_icon":0},{"id":"2584440029","title":"Tempest Therapeutics Inc - Stockholders to Receive One Warrant per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2584440029","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584440029?lang=en_us&edition=fundamental","pubTime":"2025-11-19 22:00","pubTimestamp":1763560815,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251119:nTUA20FZ9C:6","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","TPST"],"gpt_icon":0},{"id":"2584428889","title":"Tempest Therapeutics Inc: Plans to Pursue a Potential Registrational Study in Rrmm in U.S. Starting in 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2584428889","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584428889?lang=en_us&edition=fundamental","pubTime":"2025-11-19 22:00","pubTimestamp":1763560815,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251119:nTUA20FZ9C:8","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TPST","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.tempesttx.com","stockEarnings":[{"period":"1week","weight":-0.147},{"period":"1month","weight":-0.156},{"period":"3month","weight":-0.7505},{"period":"6month","weight":-0.6766},{"period":"1year","weight":-0.803},{"period":"ytd","weight":-0.1707}],"compareEarnings":[{"period":"1week","weight":-0.0133},{"period":"1month","weight":-0.0022},{"period":"3month","weight":0.0237},{"period":"6month","weight":0.0769},{"period":"1year","weight":0.1403},{"period":"ytd","weight":0.0063}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Tempest Therapeutics, Inc., a clinical-stage oncology company, develops small molecule therapeutics that combine both tumor-targeted and immune-mediated mechanisms to treat various tumors. The company's two clinical programs are TPST-1495, a dual antagonist of EP2 and EP4, receptors of prostaglandin E2, which is in a Phase 1 trial to treat solid tumors; and TPST-1120, a selective antagonist of peroxisome proliferator-activated receptor alpha that is in a Phase 1 trial for the treatment of solid tumors. It also develops TREX-1, a key cellular enzyme that regulates the innate immune response in tumors. Tempest Therapeutics, Inc. is headquartered in Brisbane, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.461538,"avgChangeRate":0.012727},{"month":2,"riseRate":0.307692,"avgChangeRate":-0.030099},{"month":3,"riseRate":0.5,"avgChangeRate":0.024061},{"month":4,"riseRate":0.25,"avgChangeRate":-0.140205},{"month":5,"riseRate":0.461538,"avgChangeRate":0.004949},{"month":6,"riseRate":0.307692,"avgChangeRate":-0.113246},{"month":7,"riseRate":0.230769,"avgChangeRate":-0.025247},{"month":8,"riseRate":0.384615,"avgChangeRate":-0.054209},{"month":9,"riseRate":0.538462,"avgChangeRate":-0.059229},{"month":10,"riseRate":0.461538,"avgChangeRate":0.94597},{"month":11,"riseRate":0.384615,"avgChangeRate":-0.081423},{"month":12,"riseRate":0.307692,"avgChangeRate":-0.062561}],"exchange":"NASDAQ","name":"Tempest Therapeutics Inc.","nameEN":"Tempest Therapeutics Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Tempest Therapeutics Inc.(TPST),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Tempest Therapeutics Inc.(TPST) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Tempest Therapeutics Inc.,TPST,Tempest Therapeutics Inc.股票,Tempest Therapeutics Inc.股票老虎,Tempest Therapeutics Inc.股票老虎国际,Tempest Therapeutics Inc.行情,Tempest Therapeutics Inc.股票行情,Tempest Therapeutics Inc.股价,Tempest Therapeutics Inc.股市,Tempest Therapeutics Inc.股票价格,Tempest Therapeutics Inc.股票交易,Tempest Therapeutics Inc.股票购买,Tempest Therapeutics Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Tempest Therapeutics Inc.(TPST),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Tempest Therapeutics Inc.(TPST) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}